Frontiers in Pharmacology | Renal Pharmacology

Editorial

Published on 16 Jun 2023

Editorial: Be positive about the negative in pharmacology: clinical studies in renal pharmacology 2022

in Renal Pharmacology

Narayan Prasad
Brijesh Yadav

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1236750

2,401 views

Review

Published on 15 Jun 2023

Mitochondrial homeostasis: a potential target for delaying renal aging

in Renal Pharmacology

Ming Yang
Chongbin Liu
Na Jiang
Yan Liu
Shilu Luo
Chenrui Li
Hao Zhao
Yachun Han
Wei Chen
Li Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1191517

3,545 views
6 citations

Original Research

Published on 13 Jun 2023

The macrocyclic lactone oxacyclododecindione reduces fibrosis progression

in Renal Pharmacology

Sabrina Saurin
Myriam Meineck
Markus Rohr
Wilfried Roth
Till Opatz
Gerhard Erkel
Andrea Pautz
Julia Weinmann-Menke

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1200164

2,525 views
2 citations

Correction

Published on 09 Jun 2023

Corrigendum: Phyllanthus niruri L. exerts protective effects against the calcium oxalate-induced renal injury via ellgic acid

in Renal Pharmacology

Mao-Ting Li
Lu-Lu Liu
Qi Zhou
Lin-Xi Huang
Yu-Xuan Shi
Jie-Bin Hou
Hong-Tao Lu
Bing Yu
Wei Chen
Zhi-Yong Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1207268

1,416 views

Original Research

Published on 08 Jun 2023

Molecular mechanism of Hedyotis Diffusae Herba in the treatment of lupus nephritis based on network pharmacology

in Renal Pharmacology

Jinfei Yang
Siying Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1118804

2,297 views
6 citations

Original Research

Published on 08 Jun 2023

The role of the SGK3/TOPK signaling pathway in the transition from acute kidney injury to chronic kidney disease

in Renal Pharmacology

Huapan Shu
Yumei Wang
Hui Zhang
Qingqing Dong
Lulu Sun
Yuchi Tu
Qianqian Liao
Li Feng
Lijun Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1169054

6,487 views
4 citations

Opinion

Published on 06 Jun 2023

Dysfunction of von-Hippel Lindau factor causes reduced degradation of HIF leading to renal cancer. Hypoxia-inducible factor-prolyl hydroxylase enzyme inhibitors also lessen HIF destruction and could therefore increase renal cancer

in Renal Pharmacology

Helge Waldum

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1170796

1,561 views
3 citations

General Commentary

Published on 30 May 2023

Commentary: Protective effect of quercetin on kidney diseases: from chemistry to herbal medicines

in Renal Pharmacology

Weiya Kong
Yage Zhang
Liangchen Luo
Qiaoyin Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1214664

2,623 views

Original Research

Published on 25 May 2023

APOC1 exacerbates renal fibrosis through the activation of the NF-κB signaling pathway in IgAN

in Renal Pharmacology

Kuipeng Yu
Lin Ding
Xin An
Yanjiang Yang
Xiaoning Zhang
Luyao Li
Chunjie Wang
Fang Bai
Xiangdong Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1181435

6,126 views
7 citations

Systematic Review

Published on 24 May 2023

Safety of HIF prolyl hydroxylase inhibitors for anemia in dialysis patients: a systematic review and network meta-analysis

in Renal Pharmacology

Dinghua Chen
Yue Niu
Fei Liu
Yue Yang
Xue Wang
Ping Li
Xiangmei Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1163908

7,860 views
12 citations

Review

Published on 23 May 2023

A comprehensive review of acute cardio-renal syndrome: need for novel biomarkers

in Renal Pharmacology

Abhi Dutta
Shubham Saha
Ajay Bahl
Anupam Mittal
Trayambak Basak

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1152055

12,506 views
15 citations

Original Research

Published on 18 May 2023

Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy

in Renal Pharmacology

Lijuan Zhao
Yanyan Yang
Hao Xu
Wei Leng
Guoshuang Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1189608

2,370 views
2 citations

Original Research

Published on 18 May 2023

In silico evidence implicating novel mechanisms of Prunella vulgaris L. as a potential botanical drug against COVID-19-associated acute kidney injury

in Renal Pharmacology

Xue-Ling Yang
Chun-Xuan Wang
Jia-Xing Wang
Shi-Min Wu
Qing Yong
Ke Li
Ju-Rong Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1188086

3,252 views
5 citations

Original Research

Published on 17 May 2023

Therapeutic mechanism of baicalein in peritoneal dialysis-associated peritoneal fibrosis based on network pharmacology and experimental validation

in Renal Pharmacology

Xiaohui Lu
Kefei Wu
Simin Jiang
Yi Li
Yating Wang
Hongyu Li
Guanglan Li
Qinghua Liu
Yi Zhou
Wei Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1153503

3,513 views
7 citations

Original Research

Published on 16 May 2023

Soluble receptors for advanced glycation end-products prevent unilateral ureteral obstruction-induced renal fibrosis

in Renal Pharmacology

Chan Ho Kim
Hye-Young Kang
Gyuri Kim
Jimin Park
Bo Young Nam
Jung Tak Park
Seung Hyeok Han
Shin-Wook Kang
Tae-Hyun Yoo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1172269

2,808 views
9 citations

Original Research

Published on 15 May 2023

Olmesartan alleviates SARS-CoV-2 envelope protein induced renal fibrosis by regulating HMGB1 release and autophagic degradation of TGF-β1

in Renal Pharmacology

Shilin Zhou
Zanzhe Yu
Zihui Chen
Fengling Ning
Xuetao Hu
Tiangang Wu
Mingxue Li
Hong Xin
Svetlana Reilly
Xuemei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1187818

2,640 views
13 citations